HTG Molecular Diagnostics, Inc. (HTGM) Financial Statements (2023 and Earlier)
Company Profile
Business Address |
3430 E. GLOBAL LOOP TUCSON, AZ 85706 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 3826 - Laboratory Analytical Instruments (benchmarking) |
More info | Complete financial analysis Financial benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 21,943 | 28,696 | 33,030 | 31,114 | 9,969 | 11,813 | 31,495 | ||
Cash and cash equivalents | 9,600 | 22,398 | 7,620 | 8,433 | 9,969 | 7,508 | 3,294 | ||
Short-term investments | 12,343 | 6,298 | 25,410 | 22,681 | 4,305 | 28,202 | |||
Restricted cash and investments | 3,270 | ||||||||
Receivables | 2,092 | 1,589 | 3,164 | 5,013 | 6,356 | 1,377 | 716 | ||
Inventory, net of allowances, customer advances and progress billings | 1,988 | 1,492 | 1,270 | 1,307 | 1,181 | 1,511 | 2,201 | ||
Inventory | 1,988 | 1,492 | 1,270 | 1,307 | 1,181 | 1,511 | 2,201 | ||
Prepaid expense | 235 | ||||||||
Deferred costs | 140 | 59 | 3 | 50 | |||||
Other undisclosed current assets | 1,163 | 1,094 | 493 | 509 | 440 | 384 | 210 | ||
Total current assets: | 27,187 | 32,871 | 41,368 | 38,001 | 17,948 | 15,134 | 34,858 | ||
Noncurrent Assets | |||||||||
Operating lease, right-of-use asset | 1,345 | 1,009 | 1,209 | ✕ | ✕ | ✕ | ✕ | ||
Property, plant and equipment | 1,119 | 1,227 | 2,240 | 2,374 | 3,305 | 3,270 | 1,932 | ||
Long-term investments and receivables | 2,604 | ||||||||
Long-term investments | 2,604 | ||||||||
Restricted cash and investments | 3,270 | ||||||||
Deferred costs | 59 | 3 | 50 | 52 | |||||
Other noncurrent assets | 809 | 90 | 302 | ||||||
Other undisclosed noncurrent assets | 67 | ||||||||
Total noncurrent assets: | 3,274 | 2,327 | 3,752 | 5,770 | 3,308 | 3,320 | 4,588 | ||
TOTAL ASSETS: | 30,461 | 35,198 | 45,119 | 43,771 | 21,256 | 18,454 | 39,447 | ||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities | 3,672 | 2,809 | 3,533 | 5,208 | 6,186 | 2,432 | 2,669 | ||
Accounts payable | 1,649 | 1,349 | 1,663 | 1,850 | 2,439 | 762 | 725 | ||
Accrued liabilities | 2,023 | 1,460 | 1,870 | 3,358 | 3,747 | 1,670 | 1,945 | ||
Deferred revenue | 125 | 185 | 426 | ✕ | ✕ | ✕ | ✕ | ||
Debt | 5,168 | 3,022 | 3,747 | 5,794 | 6,390 | 3,059 | |||
Asset retirement obligation | 548 | 513 | 1,152 | 1,290 | 496 | 605 | 544 | ||
Deferred revenue and credits | ✕ | ✕ | ✕ | ✕ | 666 | 336 | 47 | ||
Contract with customer, liability | ✕ | ✕ | ✕ | 333 | ✕ | ✕ | ✕ | ||
Other liabilities | 17 | 23 | 41 | 186 | 200 | 259 | |||
Other undisclosed current liabilities | 414 | 685 | |||||||
Total current liabilities: | 9,944 | 7,236 | 8,899 | 7,017 | 13,342 | 10,021 | 6,320 | ||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 6,159 | 8,985 | 7,508 | 9,679 | 2,961 | 5,389 | 7,790 | ||
Long-term debt, excluding current maturities | 5,179 | 8,568 | 6,872 | 9,679 | 2,961 | 5,389 | 7,790 | ||
Finance lease, liability | 31 | 48 | ✕ | ✕ | ✕ | ✕ | |||
Operating lease, liability | 949 | 369 | 636 | ✕ | ✕ | ✕ | ✕ | ||
Liabilities, other than long-term debt | 3,989 | 4,540 | 4,743 | 5,983 | 8,013 | 8,637 | 8,444 | ||
Asset retirement obligations | 3,901 | 4,479 | 4,499 | 5,703 | 7,521 | 8,017 | 8,415 | ||
Other liabilities | 88 | 60 | 244 | 280 | 492 | 620 | 29 | ||
Other undisclosed noncurrent liabilities | (49) | (48) | |||||||
Total noncurrent liabilities: | 10,100 | 13,477 | 12,251 | 15,662 | 10,974 | 14,026 | 16,234 | ||
Other undisclosed liabilities | 17 | ||||||||
Total liabilities: | 20,061 | 20,713 | 21,150 | 22,679 | 24,316 | 24,047 | 22,553 | ||
Stockholders' equity | |||||||||
Stockholders' equity attributable to parent, including: | 10,400 | 14,485 | 23,970 | 21,092 | (3,060) | (5,593) | 16,893 | ||
Preferred stock | 0 | 0 | |||||||
Common stock | 8 | 5 | 58 | 29 | 14 | 8 | 7 | ||
Treasury stock, value | (75) | (75) | |||||||
Additional paid in capital | 218,723 | 205,662 | 194,234 | 172,087 | 131,493 | 110,081 | |||
Accumulated other comprehensive income (loss) | 2 | 5 | (5) | (3) | (1) | (41) | |||
Accumulated deficit | (208,333) | (191,188) | (170,318) | (151,020) | (134,566) | (115,606) | (89,566) | ||
Other undisclosed stockholders' equity attributable to parent | 106,569 | ||||||||
Total stockholders' equity: | 10,400 | 14,485 | 23,970 | 21,092 | (3,060) | (5,593) | 16,893 | ||
TOTAL LIABILITIES AND EQUITY: | 30,461 | 35,198 | 45,119 | 43,771 | 21,256 | 18,454 | 39,447 |
Income Statement (P&L) ($ in thousands)
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 8,907 | 8,549 | 19,204 | 21,504 | 14,760 | 5,133 | 4,042 | |
Revenue, net | ✕ | ✕ | ✕ | ✕ | 14,760 | 5,133 | 4,042 | |
Cost of revenue | (4,095) | (3,992) | (8,911) | (5,090) | (4,972) | (4,136) | (3,336) | |
Cost of goods and services sold | (4,095) | (3,992) | (8,911) | (5,090) | (1,609) | (2,197) | (893) | |
Gross profit: | 4,812 | 4,557 | 10,293 | 16,413 | 9,788 | 997 | 706 | |
Operating expenses | (22,636) | (24,143) | (29,253) | (32,573) | (27,510) | (25,328) | (19,596) | |
Operating loss: | (17,824) | (19,586) | (18,960) | (16,159) | (17,723) | (24,331) | (18,890) | |
Nonoperating income (expense) | 701 | (1,270) | (334) | (291) | (1,234) | (1,698) | (2,498) | |
Interest and debt expense | (1,065) | (522) | (958) | (105) | (1,308) | (54) | (705) | |
Loss from continuing operations before equity method investments, income taxes: | (18,187) | (21,378) | (20,252) | (16,555) | (20,265) | (26,083) | (22,093) | |
Other undisclosed income from continuing operations before income taxes | 1,065 | 522 | 958 | 105 | 1,308 | 54 | 705 | |
Loss from continuing operations before income taxes: | (17,123) | (20,856) | (19,294) | (16,450) | (18,957) | (26,029) | (21,388) | |
Income tax expense | (22) | (14) | (3) | (4) | (3) | (10) | (10) | |
Net loss attributable to parent: | (17,145) | (20,870) | (19,298) | (16,454) | (18,960) | (26,040) | (21,398) | |
Preferred stock dividends and other adjustments | (1,166) | |||||||
Other undisclosed net loss available to common stockholders, basic | (163) | |||||||
Net loss available to common stockholders, diluted: | (17,145) | (20,870) | (19,298) | (16,454) | (18,960) | (26,040) | (22,726) |
Comprehensive Income ($ in thousands)
12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (17,145) | (20,870) | (19,298) | (16,454) | (18,960) | (26,040) | (21,398) | |
Other comprehensive income (loss) | (3) | 10 | (2) | (3) | 1 | 40 | (41) | |
Comprehensive loss: | (17,149) | (20,860) | (19,299) | (16,457) | (18,959) | (25,999) | (21,439) | |
Other undisclosed comprehensive loss, net of tax, attributable to parent | (1,329) | |||||||
Comprehensive loss, net of tax, attributable to parent: | (17,149) | (20,860) | (19,299) | (16,457) | (18,959) | (25,999) | (22,768) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.